While, the new relationship between the UK and the European Union (EU) has changed a few ways in which we work together, cooperation across medical research will continue. Our new trade and cooperation deal has enabled the UK’s continued participation in EU research programmes such as Horizon Europe. This means transplant researchers in the UK will still be able to apply for EU grants.
Stem cell transplant research takes place around the world, including in the UK and across Europe. Anthony Nolan is a member of the European Society of Blood and Marrow Transplantation (EBMT) and the World Marrow Donor Association (WMDA) who both represent organisations involved in making stem cell transplants possible.
Working with our community and other medical research charities, we will continue to ensure governments and policymakers understand the importance of our lifesaving research and how global relationships matter. Our influencing priorities include:
- Developing Anthony Nolan research teams by attracting and retaining talented scientists and technicians from around the world
- Supporting long-term regulatory alignment between the UK and EU on clinical trials and movement of blood, tissue and cells
- Continued coordination on pan-European research programmes, and sharing expertise across borders
If you have any questions about what Brexit means for stem cell transplants, visit our Brexit Q&A page.